Patents by Inventor Joseph E. Walton
Joseph E. Walton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8778439Abstract: Disclosed is a method of making nutritional emulsions, comprising: (A) heating and blending together an emulsifying agent having a melt point above about 25 C and oil having hydrophobic off-notes (e.g. non-encapsulated polyunsaturated fatty acid) in a weight ratio of at least about 1:15; (B) adding the heated blend to a fat, protein, and carbohydrate mixture comprising a maltodextrin (DE of about 10 or less), in a weight ratio of the maltodextrin to the oil having hydrophobic off-notes of at least about 1:2; and (C) homogenizing, and then cooling the combination below the melt point of the emulsifying agent to form a nutritional emulsion comprising from about 0.01% to about 5% by weight of process-encapsulated polyunsaturated fatty acid. The resulting nutritional emulsions effectively mask off-notes commonly associated with certain oils, e.g., polyunsaturated fatty acids, soy oil, beta-hydroxy-beta-methylbutyrate oils.Type: GrantFiled: May 17, 2011Date of Patent: July 15, 2014Assignee: Abbott LaboratoriesInventors: Chron-Si Lai, Joseph E. Walton, Charles R. Helmke, Kati E. Shearer
-
Patent number: 8648040Abstract: Disclosed are compositions, including low-calorie beverages or liquids, comprising isoleucine, leucine, valine, cysteine, and methionine, in specified amounts, weight ratios, or both. The compositions are especially useful in treating individuals afflicted with impaired glucose tolerance or diabetes.Type: GrantFiled: February 19, 2013Date of Patent: February 11, 2014Assignee: Abbott LaboratoriesInventors: Neile K. Edens, Marti S. Bergana, Kati E. Shearer, Terrence B. Mazer, Joseph E. Walton, David R. Wolf
-
Publication number: 20130165394Abstract: Disclosed are compositions, including low-calorie beverages or liquids, comprising isoleucine, leucine, valine, cysteine, and methionine, in specified amounts, weight ratios, or both. The compositions are especially useful in treating individuals afflicted with impaired glucose tolerance or diabetes.Type: ApplicationFiled: February 19, 2013Publication date: June 27, 2013Applicant: Abbott LaboratoriesInventors: Neile K. Edens, Marti S. Bergana, Kati E. Shearer, Terrence B. Mazer, Joseph E. Walton, David R. Wolf
-
Publication number: 20130122182Abstract: Disclosed are nutritional emulsions comprising fat, protein, and carbohydrate, including from about 0.01% to about 5% by weight of an oil having hydrophobic off-notes that is process-encapsulated by an emulsifying agent having a melt point above about 25 C, and maltodextrin having a DE of about 10 or less, wherein the weight ratio of the emulsifying agent to the process-encapsulated oil is at least about 1:15 and the weight ratio of the maltodextrin to the process-encapsulated oil is at least about 1:2. The nutritional emulsions effectively mask off-notes commonly associated with certain oils, e.g., polyunsaturated fatty acids, soy oil, beta-hydroxy-beta-methylbutyrate oils.Type: ApplicationFiled: May 17, 2011Publication date: May 16, 2013Applicant: ABBOTT LABORATORIESInventors: Chron-si Lai, Kati E. Shearer, Charles R. Helmke, Joseph E. Walton
-
Publication number: 20130115355Abstract: Disclosed is a method of making nutritional emulsions, comprising: (A) heating and blending together an emulsifying agent having a melt point above about 25 C and oil having hydrophobic off-notes (e.g. non-encapsulated polyunsaturated fatty acid) in a weight ratio of at least about 1:15; (B) adding the heated blend to a fat, protein, and carbohydrate mixture comprising a maltodextrin (DE of about 10 or less), in a weight ratio of the maltodextrin to the oil having hydrophobic off-notes of at least about 1:2; and (C) homogenizing, and then cooling the combination below the melt point of the emulsifying agent to form a nutritional emulsion comprising from about 0.01% to about 5% by weight of process-encapsulated polyunsaturated fatty acid. The resulting nutritional emulsions effectively mask off-notes commonly associated with certain oils, e.g., polyunsaturated fatty acids, soy oil, beta-hydroxy-beta-methylbutyrate oils.Type: ApplicationFiled: May 17, 2011Publication date: May 9, 2013Applicant: ABBOTT LABORATORIESInventors: Chron-Si Lai, Joseph E. Walton, Charles R. Helmke, Kati E. Shearer
-
Patent number: 8389471Abstract: Disclosed are compositions, including low-calorie beverages or liquids, comprising isoleucine, leucine, valine, cysteine, and methionine, in specified amounts, weight ratios, or both. The compositions are especially useful in treating individuals afflicted with impaired glucose tolerance or diabetes.Type: GrantFiled: November 9, 2010Date of Patent: March 5, 2013Assignee: Abbott LaboratoriesInventors: Neile K. Edens, Marti S. Bergana, Kati E. Shearer, Terrence B. Mazer, Joseph E. Walton, David R. Wolf
-
Publication number: 20110082097Abstract: Disclosed are compositions, including low-calorie beverages or liquids, comprising isoleucine, leucine, valine, cysteine, and methionine, in specified amounts, weight ratios, or both. The compositions are especially useful in treating individuals afflicted with impaired glucose tolerance or diabetes.Type: ApplicationFiled: November 9, 2010Publication date: April 7, 2011Applicant: ABBOTT LABORATORIESInventors: Neile K. Edens, Marti S. Bergana, Kati E. Shearer, Terrence B. Mazer, Joseph E. Walton, David R. Wolf
-
Patent number: 7879796Abstract: Disclosed are compositions, including low-calorie beverages or liquids, comprising isoleucine, leucine, valine, cysteine, and methionine, in specified amounts, weight ratios, or both. The compositions are especially useful in treating individuals afflicted with impaired glucose tolerance or diabetes.Type: GrantFiled: March 21, 2006Date of Patent: February 1, 2011Assignee: Abbott LaboratoriesInventors: Neile Edens, Marti S. Bergana, Kati Shearer, Terrence B. Mazer, Joseph E. Walton, David R. Wolf
-
Publication number: 20100260902Abstract: Disclosed are nutritional aqueous emulsions having high fiber content. These emulsions comprise fat, protein, and carbohydrate, which includes from 1.75% to about 4.0% by weight of diacylglycerol oil and from about 1.5% to about 9.0% by weight of fiber. These emulsions may also comprise fat, protein, and carbohydrate, which includes from 1% to about 4.0% of diacylglycerol oil by weight of the aqueous emulsion and from about 2.0% to about 9.0% of fiber by weight of the aqueous emulsion, wherein the aqueous emulsion has a viscosity of less than about 300 centipoise at 20° C. These high fiber emulsions provide beneficial features, including one or more of stability, desirable hedonics, rheology, and product performance, including a blunted glycemic response profile and or minimal or no gastrointestinal intolerance.Type: ApplicationFiled: April 12, 2010Publication date: October 14, 2010Inventors: Joseph E. Walton, David R. Wolf, Neile K. Edens, Vikkie A. Mustad
-
Publication number: 20100260916Abstract: Disclosed are nutritional aqueous emulsions having high fiber content. An aqueous emulsion comprising fat, protein, and carbohydrate, which includes from about 0.5% to about 9.0% by weight of a milk protein concentrate; from about 2.0% to about 6.0% by weight of glycerin, from about 2.3% to about 9.0% by weight of a fiber, and fructose and at least about 0.15% by weight of leucrose in a weight ratio of fructose to leucrose of at least 2:1, wherein the aqueous emulsion has a viscosity of less than about 300 centipoise at 20° C. These high fiber emulsions are stable and deliver desirable hedonics, rheologies, blunted glycemic profiles, and gastrointestinal tolerance. These high fiber emulsions provide beneficial features, including one or more of stability, desirable hedonics, rheology, and product performance, including a blunted glycemic response profile and or minimal or no gastrointestinal intolerance.Type: ApplicationFiled: April 12, 2010Publication date: October 14, 2010Inventors: Vikkie A. Mustad, David R. Wolf, Neile K. Edens, Joseph E. Walton
-
Publication number: 20100260917Abstract: Disclosed are nutritional aqueous emulsions having high fiber content. These emulsions comprise fat, protein, and carbohydrate, including (a) from 1.75% to about 4.0% by weight of a diacylglycerol oil; (b) from about 0.5% to about 9.0% by weight of a milk protein concentrate; (c) from about 2.0% to about 9.0% by weight of fiber; and (d) fructose and from about 0.15% by weight of leucrose in a weight ratio of fructose to leucrose of at least 2:1, wherein the aqueous emulsion has a viscosity of less than about 300 centipoise at 20° C. These high fiber emulsions provide beneficial features, including one or more of stability, desirable hedonics, rheology, and product performance, including a blunted glycemic response profile and or minimal or no gastrointestinal intolerance.Type: ApplicationFiled: April 12, 2010Publication date: October 14, 2010Inventors: Neile K. Edens, David R. Wolf, Vikkie A. Mustad, Joseph E. Walton
-
Publication number: 20090162522Abstract: Disclosed are nutritional emulsions comprising fat, protein, and carbohydrate, including: (A) an induced viscosity fiber system, and (B) a V-complex located within an aqueous phase of the emulsion and comprising a food grade surfactant complexed with a polydextrose having an average degree of polymerization of at least about 10, wherein the nutritional emulsions have a first viscosity at 20° C. of less than about 100 cps, a second viscosity at a temperature of from 0° C. to 8° C. that is at least about 50 cps higher than said first viscosity, and an induced viscosity of at least about 300 cps. The emulsions provide improved control over postprandial hunger, especially for low calorie emulsions. The emulsions also provide a thick, creamy texture when chilled.Type: ApplicationFiled: December 21, 2007Publication date: June 25, 2009Inventors: Chron-Si Lai, Joseph E. Walton, Jim-Wen R. Liu, Kati E. Shearer
-
Publication number: 20090162517Abstract: Disclosed are nutritional emulsions comprising fat, protein and carbohydrate. The emulsions include a V-complex or aqueous phase comprising a food grade surfactant complexed with a polydextrose having an average degree of polymerization of at least about 10; wherein the nutritional emulsion has a first viscosity at 20° C. of less than about 300 cps and a second viscosity at a temperature of from 0° C. to 8° C. that is at least about 50 cps higher than said first viscosity. Also disclosed is a process for the making the nutritional emulsion. The nutritional emulsions develop a surprisingly thick, creamy texture when chilled prior to use.Type: ApplicationFiled: December 21, 2007Publication date: June 25, 2009Inventors: Chron-Si Lai, Joseph E. Walton, Jim-Wen R. Liu, Kati E. Shearer, Emily A. Stepp, Terry B. Mazer
-
Publication number: 20040197380Abstract: The two component carbohydrate mixture of this invention utilizes a source of fructose in combination with at least one readily digestible glucose polymer source. The addition of the fructose significantly decreases the glycemic response when compared to the digestible glucose polymer alone. Additional components may be added to the simple two component carbohydrate mixture to form a carbohydrate system suitable for incorporation into an enteral nutritional. This carbohydrate system optionally incorporates nonabsorbent carbohydrates, dietary fiber and indigestible oligosaccharides. The present invention is also directed to an enteral nutritional which incorporates the two component carbohydrate mixture and less than 37% of calories from fat. Additionally, the invention is directed to a method of delivering nutrients to a person with diabetes by feeding the enteral nutritional.Type: ApplicationFiled: April 2, 2004Publication date: October 7, 2004Inventors: Bryan W. Wolf, Bradley A. Zinker, Keith A. Garleb, Joseph E. Walton
-
Patent number: 6774111Abstract: The two carbohydrate mixture of this invention utilizes a source of fructose in combination with at least one readily digestible glucose polymer source. The addition of the fructose significantly decreases the glycemic response when compared to the digestible glucose polymer alone. Additional components may be added to the simple two component carbohydrate mixture to form a carbohydrate system suitable for incorporation into an enteral nutritional. This carbohydrate system optionally incorporates nonabsorbent carbohydrates, dietary fiber and indigestible oligosaccharides. The present invention is also directed to an enteral nutritional which incorporates the two component carbohydrate mixture and less than 37% of calories from fat. Additionally, the invention is directed to a method of delivering nutrients to a person with diabetes by feeding the enteral nutritional.Type: GrantFiled: March 14, 2000Date of Patent: August 10, 2004Assignee: Abbott LaboratoriesInventors: Bryan W. Wolf, Bradley A. Zinker, Keith A. Garleb, Joseph E. Walton
-
Patent number: 6620434Abstract: Dosage form unit is provided to deliver one or more beneficial agents into a fluid, such as liquid enteral nutritional product. The dosage form unit includes a core containing at least one beneficial agent, preferably a marker dye, which is dispersible in the fluid. The core also contains a compatible binding agent to bind the beneficial agent together. Additional components of the core may include a plasticizer, a standard flow agent, a lubricant, additional tableting aids and at least one hydrophilic agent. A latex coating encases the core. The latex coating includes a mixture containing a substantially hydrophobic base material, preferably formed from an emulsion of cellulose acetate microspheres, which is capable of defining a matrix-type membrane, and at least one hydrophilic component being dispersible in the fluid. A dispersible beneficial agent is preferred as one of the hydrophilic components of the latex coating to allow immediate release of the beneficial agent therefrom.Type: GrantFiled: May 10, 2001Date of Patent: September 16, 2003Assignee: Abbott LaboratoriesInventors: Terrence B. Mazer, Joseph E. Walton, Barbara S. Arnholt, Monty L. Evans, Ronita K. Geckle, Daniel Hamilton, John J. Kropczynski, Jr., Frank A. Murawski, Larry G. Tucker, Sherri A. Walker, Michael V. Walsh, Rhonda Cole Walsh
-
Patent number: 6309373Abstract: An apparatus for altering characteristics of a fluid. The apparatus includes a canister having a side wall, a first end wall, and a second end wall defining a chamber therein. A beneficial agent is disposed in the chamber. The end walls define apertures therethrough. The apparatus further includes a tubing portion defining a first end portion constructed for connection to a fluid source and an outlet portion. The tubing portion also defines a canister-receiving portion intermediate the first end portion and the outlet portion. The canister-receiving portion defines a first fluid flow channel fluidly connecting the first end portion and the second outlet portion of said tubing portion. The canister-receiving portion also defines first and second fluid flow orifices therethrough.Type: GrantFiled: August 12, 1998Date of Patent: October 30, 2001Assignee: Abbott LaboratoriesInventors: Robert A. Shalwitz, Rhonda L. Cole, Ronita K. Geckle, John J. Kropczynski, Terrence B. Mazer, Joseph E. Walton
-
Publication number: 20010024663Abstract: Dosage form unit is provided to deliver one or more beneficial agents into a fluid, such as liquid enteral nutritional product. The dosage form unit includes a core containing at least one beneficial agent, preferably a marker dye, which is dispersible in the fluid. The core also contains a compatible binding agent to bind the beneficial agent together. Additional components of the core may include a plasticizer, a standard flow agent, a lubricant, additional tableting aids and at least one hydrophilic agent. A latex coating encases the core. The latex coating includes a mixture containing a substantially hydrophobic base material, preferably formed from an emulsion of cellulose acetate microspheres, which is capable of defining a matrix-type membrane, and at least one hydrophilic component being dispersible in the fluid. A dispersible beneficial agent is preferred as one of the hydrophilic components of the latex coating to allow immediate release of the beneficial agent therefrom.Type: ApplicationFiled: May 10, 2001Publication date: September 27, 2001Inventors: Terrence B. Mazer, Joseph E. Walton, Barbara S. Arnholt, Monty L. Evans, Ronita K. Geckle, Daniel Hamilton, John J. Kropczynski, Frank A. Murawski, Larry G. Tucker, Sherri A. Walker, Michael V. Walsh, Rhonda Cole Walsh
-
Patent number: 6277092Abstract: An apparatus for modifying a liquid enteral nutritional product. The apparatus includes a chamber having an inlet and an outlet. The inlet of the chamber is constructed to be fluidly connected to a supply container containing a liquid enteral nutritional. The chamber defines an interior space. The apparatus further includes a retainer disposed in the interior space defined by the chamber. The retainer is constructed to receive one or more dosage form units of beneficial agent therein. The apparatus further includes at least one dosage form unit of beneficial agent retained by the retainer.Type: GrantFiled: February 27, 1998Date of Patent: August 21, 2001Assignee: Abbott LaboratoriesInventors: Rhonda L. Cole, Ronita K. Geckle, Terrence B. Mazer, Frank A. Murawski, Carl J. Piontek, Gregory James Stephens, Joseph E. Walton
-
Patent number: 6251432Abstract: Dosage form unit is provided to deliver one or more beneficial agents into a fluid, such as liquid enteral nutritional product. The dosage form unit includes a core containing at least one beneficial agent, preferably a marker dye, which is dispersible in the fluid. The core also contains a compatible binding agent to bind the beneficial agent together. Additional components of the core may include a plasticizer, a standard flow agent, a lubricant, additional tableting aids and at least one hydrophilic agent. A latex coating encases the core. The latex coating includes a mixture containing a substantially hydrophobic base material, preferably formed from an emulsion of cellulose acetate microspheres, which is capable of defining a matrix-type membrane, and at least one hydrophilic component being dispersible in the fluid. A dispersible beneficial agent is preferred as one of the hydrophilic components of the latex coating to allow immediate release of the beneficial agent therefrom.Type: GrantFiled: July 1, 1999Date of Patent: June 26, 2001Assignee: Abbott LaboratoriesInventors: Terrence B. Mazer, Joseph E. Walton, Barbara S. Arnholt, Monty L. Evans, Ronita K. Geckle, Daniel Hamilton, John J. Kropczynski, Jr., Frank A. Murawski, Larry G. Tucker, Sherri A. Walker, Michael V. Walsh, Rhonda Cole Walsh